相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ALSUntangled #61: melatonin
Richard Bedlack et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2022)
Improving clinical trial outcomes in amyotrophic lateral sclerosis
Matthew C. Kiernan et al.
NATURE REVIEWS NEUROLOGY (2021)
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
Tesfaye Wolde Tefera et al.
CELL AND BIOSCIENCE (2021)
Small Molecule SARM1 Inhibitors Recapitulate the SARM1-/- Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate
Robert O. Hughes et al.
CELL REPORTS (2021)
The Efficacy of Ketogenic Therapies in the Clinical Management of People with Neurodegenerative Disease: A Systematic Review
Lauren S. Dewsbury et al.
ADVANCES IN NUTRITION (2021)
Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide-induced microglial and astrocytic neuroinflammation by increasing NAD+
Jureepon Roboon et al.
JOURNAL OF NEUROCHEMISTRY (2021)
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Mihoko Yoshino et al.
SCIENCE (2021)
Nicotinamide N-methyltransferase in endothelium protects against oxidant stress-induced endothelial injury
Roberto Campagna et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2021)
The Link between Oxidative Stress, Redox Status, Bioenergetics and Mitochondria in the Pathophysiology of ALS
Elena Obrador et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
NADPH Oxidases (NOX): An Overview from Discovery, Molecular Mechanisms to Physiology and Pathology
Annelise Vermot et al.
ANTIOXIDANTS (2021)
Nicotinamide Riboside and Pterostilbene Cooperatively Delay Motor Neuron Failure in ALS SOD1G93A Mice
Elena Obrador et al.
MOLECULAR NEUROBIOLOGY (2021)
Targeting NAD+ in translational research to relieve diseases and conditions of metabolic stress and ageing
Brian C. Gilmour et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2020)
ALS phenotype is influenced by age, sex, and genetics: A population-based study
Adriano Chio et al.
NEUROLOGY (2020)
Niacin Cures Systemic NAD+ Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy
Eija Pirinen et al.
CELL METABOLISM (2020)
Evaluation of the NAD+ biosynthetic pathway in ALS patients and effect of modulating NAD+ levels in hSOD1-linked ALS mouse models
Benjamin A. Harlan et al.
EXPERIMENTAL NEUROLOGY (2020)
Genetics and Sex in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS): Is There a Link?
Francesca Trojsi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Possible Adverse Effects of High-Dose Nicotinamide: Mechanisms and Safety Assessment
Eun Seong Hwang et al.
BIOMOLECULES (2020)
Nicotinamide adenine dinucleotide (NAD+): essential redox metabolite, co-substrate and an anti-cancer and anti-ageing therapeutic target
Hollie B. S. Griffiths et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2020)
Amyotrophic lateral sclerosis: a clinical review
P. Masrori et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
What do we know about the variability in survival of patients with amyotrophic lateral sclerosis?
Pamela A. McCombe et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2020)
Nicotinamide mononucleotide administration after sever hypoglycemia improves neuronal survival and cognitive function in rats
Xiaonan Wang et al.
BRAIN RESEARCH BULLETIN (2020)
Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders
Abid Bhat et al.
PHARMACOLOGICAL RESEARCH (2020)
Oxidative Stress: Concept and Some Practical Aspects
Helmut Sies
ANTIOXIDANTS (2020)
Secondary Metabolites with Antioxidant Activities for the Putative Treatment of Amyotrophic Lateral Sclerosis (ALS): Experimental Evidences
Jamire M. Silva et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention
Teresa Cunha-Oliveira et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Post-Marketing Experience of Edaravone in Amyotrophic Lateral Sclerosis: A Clinical Perspective and Comparison With the Clinical Trials of the Drug
Juan Fernando Ortiz et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
NAD+metabolism: pathophysiologic mechanisms and therapeutic potential
Na Xie et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
NAD(+) homeostasis in health and disease
Elena Katsyuba et al.
NATURE METABOLISM (2020)
Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes
Nady Braidy et al.
ANTIOXIDANTS & REDOX SIGNALING (2019)
The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson's disease
Ian F. Harrison et al.
JOURNAL OF NEUROCHEMISTRY (2019)
NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression
Chunjing Bian et al.
NATURE COMMUNICATIONS (2019)
Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study
Jose E. de la Rubia et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2019)
Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development
Natalia Robledinos-Anton et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults
Dietrich Conze et al.
SCIENTIFIC REPORTS (2019)
Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures
Yasir S. Elhassan et al.
CELL REPORTS (2019)
NAD+ in Brain Aging and Neurodegenerative Disorders
Sofie Lautrup et al.
CELL METABOLISM (2019)
Cromolyn sodium delays disease onset and is neuroprotective in the SOD1G93A Mouse Model of amyotrophic lateral sclerosis
Eric J. Granucci et al.
SCIENTIFIC REPORTS (2019)
Keeping the balance in NAD metabolism
Oyvind Stromland et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2019)
Efficacy and safety of edaravone in treatment of amyotrophic lateral sclerosisa systematic review and meta-analysis
Linting Luo et al.
NEUROLOGICAL SCIENCES (2019)
Younger age of onset in familial amyotrophic lateral sclerosis is a result of pathogenic gene variants, rather than ascertainment bias
Puja R. Mehta et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Slc12a8 is a nicotinamide mononucleotide transporter
Alessia Grozio et al.
NATURE METABOLISM (2019)
Nicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration
Mariana Pehar et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline
Mariana G. Tarrago et al.
CELL METABOLISM (2018)
Decreased glutathione levels cause overt motor neuron degeneration in hSOD1WT over-expressing mice
Kelby M. Killoy et al.
EXPERIMENTAL NEUROLOGY (2018)
The NAD plus Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson's Disease
David C. Schoendorf et al.
CELL REPORTS (2018)
Amyotrophic lateral sclerosis
Orla Hardiman et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Oxidative Stress
Helmut Sies et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 86 (2017)
Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
Ryan W. Dellinger et al.
NPJ AGING AND MECHANISMS OF DISEASE (2017)
Enhancing NAD+ Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1)
Benjamin A. Harlan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Nicotinamide mononucleotide inhibits post-ischemic NAD+ degradation and dramatically ameliorates brain damage following global cerebral ischemia
Ji H. Park et al.
NEUROBIOLOGY OF DISEASE (2016)
Increased oxidative stress in patients with amyotrophic lateral sclerosis and the effect of edaravone administration
Midori Nagase et al.
REDOX REPORT (2016)
NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
Joanna Ratajczak et al.
NATURE COMMUNICATIONS (2016)
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Samuel A. J. Trammell et al.
NATURE COMMUNICATIONS (2016)
SARM1 activation triggers axon degeneration locally via NAD+ destruction
Josiah Gerdts et al.
SCIENCE (2015)
Motor cortex glutathione deficit in ALS measured in vivo with the J-editing technique
N. Weiduschat et al.
NEUROSCIENCE LETTERS (2014)
Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: Pooled results from 5 cohort studies
Kathryn C. Fitzgerald et al.
ANNALS OF NEUROLOGY (2013)
Mammalian SOD2 is exclusively located in mitochondria and not present in peroxisomes
Srikanth Karnati et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2013)
CD73 Protein as a Source of Extracellular Precursors for Sustained NAD+ Biosynthesis in FK866-treated Tumor Cells
Alessia Grozio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Nitric Oxide-Mediated Oxidative Damage and the Progressive Demise of Motor Neurons in ALS
Derek A. Drechsel et al.
NEUROTOXICITY RESEARCH (2012)
Phase II Trial of CoQ10 for ALS Finds Insufficient Evidence to Justify Phase III
Petra Kaufmann et al.
ANNALS OF NEUROLOGY (2009)
SIRT1 Promotes Cell Survival under Stress by Deacetylation-Dependent Deactivation of Poly(ADP-Ribose) Polymerase 1
Senthilkumar B. Rajamohan et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Nicotinamide Prevents NAD+ Depletion and Protects Neurons Against Excitotoxicity and Cerebral Ischemia: NAD+ Consumption by SIRT1 may Endanger Energetically Compromised Neurons
Dong Liu et al.
NEUROMOLECULAR MEDICINE (2009)
Nicotinic acid nicotinamide and nicotinamide riboside: A molecular evaluation of NAD(+) precursor vitamins in human nutrition
Katrina L. Bogan et al.
ANNUAL REVIEW OF NUTRITION (2008)
SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons
Ying Li et al.
CELL METABOLISM (2008)
Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice
Hidefumi Ito et al.
EXPERIMENTAL NEUROLOGY (2008)
Differences among cell types in NAD+ compartmentalization:: A comparison of neurons, astrocytes, and cardiac myocytes
Conrad C. Alano et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells
Nobumasa Hara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis
J. H. Veldink et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
NAD+ metabolism in health and disease
Peter Belenky et al.
TRENDS IN BIOCHEMICAL SCIENCES (2007)
Voltage-dependent sodium channels in spinal cord motor neurons display rapid recovery from fast inactivation in a mouse model of amyotrophic lateral sclerosis
Cristina Zona et al.
JOURNAL OF NEUROPHYSIOLOGY (2006)
Reduced oxidative damage in ALS by high-dose enteral melatonin treatment
Jochen H. Weishaupt et al.
JOURNAL OF PINEAL RESEARCH (2006)
Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy
Yo Sasaki et al.
JOURNAL OF NEUROSCIENCE (2006)
Dual effects of antioxidants in neurodegeneration: Direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation
Jia-Yi Wang et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
NAD metabolism and sirtuins: Metabolic regulation of protein deacetylation in stress and toxicity
Tianle Yang et al.
AAPS JOURNAL (2006)
The sirtuin inhibitor nicotinamide enhances neuronal cell survival, during acute anoxic injury through AKT, BAD, PARP, and mitochondrial associated anti-apoptotic pathways
ZZ Chong et al.
CURRENT NEUROVASCULAR RESEARCH (2005)
Mechanism of sirtuin inhibition by nicotinamide:: Altering the NAD+ cosubstrate specificity of a Sir2 enzyme
JL Avalos et al.
MOLECULAR CELL (2005)
Navigating novel mechanisms of cellular plasticity with the NAD+ precursor and nutrient nicotinamide
FQ Li et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
PARP-1, a determinant of cell survival in response to DNA damage
WJ Bouchard et al.
EXPERIMENTAL HEMATOLOGY (2003)
Antioxidants as treatment for neurodegenerative disorders
B Moosmann et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2002)
Tumoricidal activity of endothelial cells -: Inhibition of endothelial nitric oxide production abrogates tumor cytotoxicity induced by hepatic sinusoidal endothelium in response to B16 melanoma adhesion in vitro
J Carretero et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
NAD(P)H, a directly operating antioxidant?
M Kirsch et al.
FASEB JOURNAL (2001)
Control of mitochondrial redox balance and cellular defense against oxidative damage by mitochondrial NADP+-dependent isocitrate dehydrogenase
SH Jo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A double-blind, placebo-controlled randomized clinical trial of α-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis
C Desnuelle et al.
AMYOTROPHIC LATERAL SCLEROSIS (2001)
N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis
OA Andreassen et al.
NEUROREPORT (2000)
Quantitative biochemical and ultrastructural comparison of mitochondrial permeability transition in isolated brain and liver mitochondria: Evidence for reduced sensitivity of brain mitochondria
SB Berman et al.
EXPERIMENTAL NEUROLOGY (2000)
分享论文
